Table 2.
Advanced PD group.
| Subject | Sex | Age | Stage1 | UPDRS | Symptoms (years)2 | Medicines |
|---|---|---|---|---|---|---|
| 1*(DBS@47) | M | 52 | 3 | 27 | 14 | A; L; Pra |
| 2*(DBS @48) | M | 59 | 4 | 42 | 19 | L |
| 3*(DBS @70) | F | 81 | 4 | 38 | 20 | L; Pra |
| 4 | F | 64 | 3 | 28 | 4 | L |
| 5 | M | 41 | 2 | 15 | 2 | A; L |
| 6 | M | 57 | 3 | 29 | 4 | L; Pra |
| 7 | M | 49 | 3 | 42 | 6 | Ras; Rop; Tri |
| 8 | M | 70 | 3 | 31 | 3 | L |
| 9 | M | 80 | 4 | 42 | 9 | L |
| 10 | F | 67 | 3 | 31 | 5 | L; Ras |
| 11 | F | 77 | 4 | 35 | 6 | L; Pra |
| 12 | F | 55 | 3 | 27 | 6 | L; Ras; Rop |
| 13 | M | 77 | 3 | 31 | 7 | Don; L |
| 14 | M | 72 | 2 | 21 | 8 | L; Pra; Ras |
| 15 | M | 54 | 4 | 42 | 9 | L; Rop; Sel |
| 16 | M | 60 | 3 | 35 | 10 | A |
| 17 | F | 69 | 2 | 18 | 12 | L; Pra; Ras |
| Summary | 6F/11M | 63.7 ± 11.7 | 3.1 ± 0.7 | 31.4 ± 8.4 | 8.4 ± 5.2 | |
Demographic and clinical features of 17 PD patients tested in the “off” state (UPDRS unified PD rating scale; motor subscale. Antiparkinsonian medication as in Table 1; Ras, rasagiline; Rop, ropinirole.
*Deep Brain Stimulation at age.
1Hoehn and Yahr stage.
2Refers to number of years since first remembered parkinsonian symptoms.